Original Research

Published on 27 Mar 2019

Polytropic Influence of TRIB3 rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension

in Pharmacogenetics and Pharmacogenomics

Jiecan Zhou
Fazhong He
Bao Sun
Rong Liu
Yongchao Gao
Huan Ren
Yan Shu
Xiaoping Chen
Zhaoqian Liu
Honghao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00236

4,614 views
7 citations

Original Research

Published on 26 Mar 2019

A Screening Test for HLA-B∗15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events

in Pharmacogenetics and Pharmacogenomics

Hua Fang
Xiequn Xu
Kulvinder Kaur
Matthew Dedek
Guang-dan Zhu
Bae J. Riley
Frank G. Espin
Andria L. Del Tredici
Tanya A. Moreno

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00149

22,089 views
24 citations

Original Research

Published on 18 Mar 2019

Pharmacokinetic and Pharmacogenetic Factors Contributing to Platelet Function Recovery After Single Dose of Ticagrelor in Healthy Subjects

in Pharmacogenetics and Pharmacogenomics

Qian Zhu
Wanping Zhong
Xipei Wang
Liping Mai
Guodong He
Jiyan Chen
Lan Tang
Shuwen Liu
Weihua Lai
Shilong Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00209

4,238 views
13 citations

Original Research

Published on 14 Mar 2019

Actionable Pharmacogenetic Variation in the Slovenian Genomic Database

in Pharmacogenetics and Pharmacogenomics

Keli Hočevar
Aleš Maver
Borut Peterlin

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00240

6,039 views
11 citations

Original Research

Published on 04 Mar 2019

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients

in Pharmacogenetics and Pharmacogenomics

Wei Zhou
Yong Xu
Qinyu Lv
Yong-hui Sheng
Luan Chen
Mo Li
Lu Shen
Cong Huai
Zhenghui Yi
Donghong Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00177

5,440 views
15 citations

Review

Published on 19 Feb 2019

Making Sense of the Epigenome Using Data Integration Approaches

in Pharmacogenetics and Pharmacogenomics

Emma Cazaly
Joseph Saad
Wenyu Wang
Caroline Heckman
Miina Ollikainen
Jing Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00126

26,509 views
54 citations

Original Research

Published on 19 Feb 2019

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders

in Pharmacogenetics and Pharmacogenomics

Stacey L. Aldrich
Ethan A. Poweleit
Cynthia A. Prows
Lisa J. Martin
Jeffrey R. Strawn
Laura B. Ramsey

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00099

24,979 views
83 citations

Original Research

Published on 07 Feb 2019

Beta2-Adrenergic Receptor Polymorphisms and Haplotypes Associate With Chronic Pain in Sickle Cell Disease

in Pharmacogenetics and Pharmacogenomics

Ellie H. Jhun
Nilanjana Sadhu
Xiaoyu Hu
Yingwei Yao
Ying He
Diana J. Wilkie
Robert E. Molokie
Zaijie Jim Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00084

4,378 views
11 citations

Original Research

Published on 28 Jan 2019

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

in Pharmacogenetics and Pharmacogenomics

Sara Redenšek
Dušan Flisar
Maja Kojović
Milica Gregorič Kramberger
Dejan Georgiev
Zvezdan Pirtošek
Maja Trošt
Vita Dolžan

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00008

9,621 views
40 citations

Original Research

Published on 11 Dec 2018

Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications

in Pharmacogenetics and Pharmacogenomics

Fazhong He
Yan Shu
Xingyu Wang
Xin Liu
Guojing Liu
Zhangren Chen
Zhenmin Wang
Ling Li
Rong Liu
Honghao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01422

3,114 views
11 citations

Review

Published on 04 Dec 2018

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data

in Pharmacogenetics and Pharmacogenomics

Yitian Zhou
Kohei Fujikura
Souren Mkrtchian
Volker M. Lauschke

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01437

9,909 views
57 citations

Review

Published on 04 Dec 2018

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit

in Pharmacogenetics and Pharmacogenomics

Shuqin Zhou
Debra J. Skaar
Pamala A. Jacobson
R. Stephanie Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01436

48,634 views
18 citations

Original Research

Published on 03 Dec 2018

Genetic Interaction Between Two VNTRs in the SLC6A4 Gene Regulates Nicotine Dependence in Vietnamese Men

in Pharmacogenetics and Pharmacogenomics

Gea Kõks
Ele Prans
Ha Diep Thi Tran
Ngoc Bich Thi Ngo
Linh Nhat Nguyen Hoang
Hue Minh Thi Tran
Thanh Cao Ngoc
Thuoc Doan Phuoc
Xuan Dung Ho
Binh Ho Duy

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01398

4,146 views
8 citations

Review

Published on 22 Nov 2018

Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development

in Pharmacogenetics and Pharmacogenomics

Dominik D. Kaltenbach
Dinesh Jaishankar
Meng Hao
Jacob C. Beer
Michael V. Volin
Umesh R. Desai
Vaibhav Tiwari

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01315

5,497 views
19 citations

Case Report

Published on 15 Nov 2018

Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma

in Pharmacogenetics and Pharmacogenomics

Lisa M. Velez-Velez
Caren L. Hughes
Pashtoon Murtaza Kasi

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01309

4,941 views
9 citations

Original Research

Published on 14 Nov 2018

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients

in Pharmacogenetics and Pharmacogenomics

Antony Brayan Campos-Salazar
Fabiana Dalla Vecchia Genvigir
Claudia Rosso Felipe
Helio Tedesco-Silva
José Medina-Pestana
Gabriela Vieira Monteiro
Rodrigo de Gouveia Basso
Alvaro Cerda
Mario Hiroyuki Hirata
Rosario Dominguez Crespo Hirata

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01296

3,786 views
8 citations

Navigation group

Articles

Polytropic Influence of TRIB3 rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension

A Screening Test for HLA-B∗15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events

Pharmacokinetic and Pharmacogenetic Factors Contributing to Platelet Function Recovery After Single Dose of Ticagrelor in Healthy Subjects

Actionable Pharmacogenetic Variation in the Slovenian Genomic Database

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients

Making Sense of the Epigenome Using Data Integration Approaches

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders

Beta2-Adrenergic Receptor Polymorphisms and Haplotypes Associate With Chronic Pain in Sickle Cell Disease

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit

Genetic Interaction Between Two VNTRs in the SLC6A4 Gene Regulates Nicotine Dependence in Vietnamese Men

Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development

Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients